Chromosome 7 open reading frame 57 is an uncharacterized protein found in humans and several other homologs. It is encoded by the C7orf57 gene. This gene is found to be greatly expressed in the fallopian tubes, testes, lungs, hippocampus, hypothalamus, and caudate.[5] There are three isoforms of the gene. Within the gene sequence 9 exons are present. C7orf57 has been linked to lupus,[6] pancreatic cancer[7] sporadic amyotrophic lateral sclerosis.[8] and gastrointestinal toxicity[9]

C7orf57
Identifiers
AliasesC7orf57, chromosome 7 open reading frame 57
External IDsMGI: 3651127; HomoloGene: 77951; GeneCards: C7orf57; OMA:C7orf57 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001100159
NM_001267865
NM_001267866

NM_001037928

RefSeq (protein)

NP_001093629
NP_001254794
NP_001254795

NP_001033017

Location (UCSC)Chr 7: 48.04 – 48.06 MbChr 11: 9 – 9.02 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Gene

edit

There are three isoforms of C7orf57. Isoform 1 is the longest of the three with 2102 residues and 9 exons. The protein sequence is 295 base pairs. Its locus is 7p12.3. It is often found in nuclear and mitochondrial sub cellular locations.[10]

C7orf57 has a promoter upstream of its transcription site as found in Genomatix.[11] The promoter is 1125 base pairs long, located between 48024511-48025635. It codes for six transcripts of C7orf57.

Protein

edit

Post translation modifications

edit

There are many phosphorylation sites found on the protein, mostly on serine and threonine. There are also many  glycosylation sites.

Secondary structure

edit

C7orf57 does not have a known secondary structure, though it is predicted to consist mainly of random coils with some alpha helixes. It is predicted to be similar in structure to Phosphoribosylanthranilate isomerase.

Tissue expression

edit

C7orf57 has increased expressed in the larynx, testis, fallopian tubes, lungs, and parts of the brain. It is expressed in lower amounts with pathology.[12]

Evolution

edit

Orthologs have been found in mammals, ranging from primates to amphibians. There are also orthologs found in more distant species such as birds, reptiles, and fish with the most distant relative being a whale shark. There are two paralogs of the gene, for actin a and actin b. The gene has evolved at a steady pace when compared to a slow and a fast evolving gene.

Homologs
Species Median Date of Divergence (MYA) % Identity
Humans 0 100
Orangutan 15.2 96.27
Gibbon 19.4 95.59
Tarsier 66.7 84.53
Horse 94 77.29
Seal 94 71.48
Armadillo 102 71.48
Killdeer 320 58.16
Ostrich 320 56.5
Turkey 320 51.05
Green Anole 320 51
Burmese Python 320 50.9
Pit Viper 320 50
Japanese Gekko 320 47.22
Zebra Finch 320 46.96
Crow 320 41.38
Tibetan Frog 353 47.79
Tropical Clawed Frog 353 45.9
American Bullfrog 353 44.35
Elephant Shark 465 29.11
 
Secondary structure of C7orf57 made using Cn3d[13]

Clinical significance

edit

C7orf57 has been linked to several diseases, including pancreatic cancer, sporadic amyotrophic lateral sclerosis (ALS), systematic lupus erythematous (SLE), and gastrointestinal toxicity. In a study that analyzed pancreatic cancer cells, it was found that when a patient was treated with metformin and aspirin, C7orf57 was unregulated by over 10 fold.[7] Another disease of interest is gastrointestinal toxicity. A high correlation between C7orf57 and an increased risk of experiencing severe gastrointestinal toxicity was found with a  r2 value of 1.0[9] For ALS, the gene was found to have a nonrandom association with one of the SNPs associated with the disease. However, genome-wide significance was not achieved.[8] The gene is also linked to Lupus as to SNPs in its locus were found to be related to serum IFN-α activity, which is elevated in many lupus patients and therefore is thought to be a causing factor. Like in the ALS study, the locus failed to replicate.[6]

C7orf57 was found to have lower expression than normal when studying individuals with endometriosis and nasopharyngeal carcinoma, a cancer of the head and neck[14]

References

edit
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000164746Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000040978Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ "Tissue expression of C7orf57 - Summary - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2019-02-08.
  6. ^ a b Kariuki SN, Ghodke-Puranik Y, Dorschner JM, Chrabot BS, Kelly JA, Tsao BP, et al. (January 2015). "Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus". Genes and Immunity. 16 (1): 15–23. doi:10.1038/gene.2014.57. PMC 4305028. PMID 25338677.
  7. ^ a b Yue W, Wang T, Zachariah E, Lin Y, Yang CS, Xu Q, DiPaola RS, Tan XL (August 2015). "Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy". Scientific Reports. 5: 13390. Bibcode:2015NatSR...513390Y. doi:10.1038/srep13390. PMC 4543968. PMID 26294325.
  8. ^ a b Chiò A, Schymick JC, Restagno G, Scholz SW, Lombardo F, Lai SL, et al. (April 2009). "A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis". Human Molecular Genetics. 18 (8): 1524–32. doi:10.1093/hmg/ddp059. PMC 2664150. PMID 19193627.
  9. ^ a b Corrigan, A. (21026). An Investigation of the Pharmocogenetic Basis of Toxicity to Platinum Chemotherapy Agents (Unpublished master's thesis). Kings College.
  10. ^ "PSORT II Prediction".
  11. ^ "Genomatix Annotation".
  12. ^ Tissue Expression of C7orf57 - Summary - The Human Protein Atlas, www.proteinatlas.org/ENSG00000164746-C7orf57/tissue.
  13. ^ "Cn3d macromolecule structure viewer".
  14. ^ Hawkins SM, Creighton CJ, Han DY, Zariff A, Anderson ML, Gunaratne PH, Matzuk MM (May 2011). "Functional microRNA involved in endometriosis". Molecular Endocrinology. 25 (5): 821–32. doi:10.1210/me.2010-0371. PMC 3082329. PMID 21436257.